Transforming growth factor alpha- and c-myc-induced mammary carcinogenesis in transgenic mice (original) (raw)

References

• Amundadottir LT, Johnson MD, Merlino G, Smith GH and Dickson RB. . 1995 Cell Growth Diff. 6: 737–748.
• Amundadottir LT, Nass SJ, Berchem GJ, Johnson MD and RB Dickson. . 1996 Oncogene 13: 757–765.
• Andres AC, van der Valk MA, Schoenenberger CA, Fluckiger F, LeMeur M, Gerlinger P and Groner B. . 1988 Genes Dev. 2: 1486–1495.
• Bayna EM and Rosen JM. . 1990 Nucleic Acids Res. 18: 2977–2985.
• Berns EM, Klign JG, Smid M, van Staveren IL, Look MP, van Putten WL and Foekens JA. . 1996 Genes Chrom. Cancer 16: 170–179.
• Brachmann R, Lindquist PB, Nagashima M, Kohr W, Lipari T, Napier M and Derynk R. . 1989 Cell 56: 691–700.
• Christensen ME and Poulsen SS. . 1996 Histochem. Cell Biol. 105: 391–400.
• Davies BR, Platt-Higgins AM, Schmidt G and Rudland PS. . 1999 Am. J. Pathol. 155: 303–314.
• de Larco JE and Todaro GJ. . 1978 PNAS. 75: 4001–4005.
• Derynck R. . 1992 Adv. Cancer Res. 58: 27–52.
• Dubik D, Watson PH, Venditti M and Shiu RPC. . 1996 In: Mammary Tumor Cell Cycle, Differentiation and Metastasis. Dickson R and Lippman M. (eds).. Kluwer Academic Publishers: Boston, MA. pp. 171–189.
  Book Google Scholar
• Halter SA, Dempsey P, Matsui Y, Stokes MK, Graves-Deal R, Hogan BLM and Coffey RJ. . 1992 Am. J. Path. 140: 1131–1146.
• Jager R, Herzer U, Schenkel J and Weiher H. . 1997 Oncogene 15: 1787–1795.
• Jhappan C, Stahle C, Harkins RN, Fausto N, Smith GH and Merlino GT. . 1990 Cell 61: 1121–1135.
• Kumar V, Bustin SA and McKay IA. . 1995 Cell Biol. Inter. 19: 373–388.
• Leder A, Pattengale PK, Kuo A, Stewart TA and Leder P. . 1986 Cell 45: 485–495.
• Lee DC, Luetteke NC and Petch LA. . 1992 Cancer Treat. Res. 63: 233–254.
• Lee DC, Fenton SE, Berkowitz EA and Hissong MA. . 1995 Pharmacol. Rev. 47: 51–85.
• McCormack SJ, Weaver Z, Deming S, Natarajan G, Torri J, Johnson MD, Liyanage M, Ried T and Dickson RB. . 1998 Oncogene 28: 2755–2766.
• Matsui Y, Halter SA, Holt JT, Hogan BLM and Coffey RJ. . 1990 Cell 61: 1147–1155.
• Muller WJ, Arteaga CL, Muthuswamy SK, Siegel PM, Webster MA, Cardiff Rd, Meise KS, Li F, Halter SA and Coffey RJ. . 1996 Mol. Cell. Biol. 16: 5726–5736.
• Nass SJ and Dickson RB. . 1997 Breast Cancer Res. Treat. 44: 1–22.
• Pittius CW, Sankaran L, Topper YJ and Hennighausen L. . 1988 Mol. Endocrinol. 2: 1027–1032.
• Robinson GW, McKnight RA, Smith GH and Hennighausen L. . 1995 Development 121: 2079–2090.
• Robinson GW, Smith GH, Gallahan D, Zimmer A, Furth PA and Hennighausen L. . 1996 Dev. Dynam. 206: 159–168.
• Rudland PS, Fernig DG and Smith JA. . 1995 Biomed. Pharmacol. 49: 389–399.
• Sandgren EP, Luetteke NC, Palmiter RD, Brinster RL and Lee DC. . 1990 Cell 61: 1121–1135.
• Sandgren EP, Schroeder JA, Qui TH, Palmiter RD, Brinster RL and Lee DC. . 1995 Cancer Res. 55: 3915–3927.
• Santarelli R, Tzeng YJ, Zimmermann C, Guhl E and Graessmann A. . 1996 Oncogene 12: 495–505.
• Schoenenberger CA, Andres AC, Groner B, van der valk M, LeMeur M and Gerlinger P. . 1988 EMBO J. 7: 169–175.
• Sinn E, Muller W, Pattengale P, Tepler I, Wallace R and Leder P. . 1987 Cell 49: 465–475.
• Smith GH, Sharp R, Kordon EC, Jhappan C and Merlino G. . 1995 Am. J. Pathol. 147: 1081–1096.
• Stewart TA, Pattengale PK and Leder P. . 1984 Cell 38: 627–637.
• Wong ST, Winchell LF, McCune BK, Earp HS, Teixido J, Massague J, Herman B and Lee DC. . 1989 Cell 56: 495–506.

Download references